About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
All categories
All categories
News
Press releases
Press about us
Portfolio
Portfolio
Genetico
Gemabank
Histograft
Nextgen
Genotarget
Biotechnology Developments
Betuvax
Reprobank
Vitacel
29.07.2024
Press releases
Artgen Biotech performance for 6 months of 2024 according to RAS
25.07.2024
Press releases
Gemabank Results for 6 months of 2024 according to RAS
24.07.2024
Press releases
ACRA upgraded the credit rating of IMCB, PJSC, to BBB-(RU) with a Stable outlook
18.07.2024
Press releases
ACRA upgraded the credit rating of Artgen Biotech to BBB-(RU), and the forecast is «Stable»
11.07.2024
Press releases
Histograft received a patent in the USA
10.07.2024
Press releases
Rostec received permission to conduct clinical trials of Russia’s first vaccine against influenza and coronavirus
08.07.2024
Press releases
ACRA confirmed the credit rating of International Medical Center for Biomaterials PJSC at BB+(RU), and the forecast is «Stable»
1
2
3
4
…
14
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
